D. Tsantoulas

674 total citations
17 papers, 501 citations indexed

About

D. Tsantoulas is a scholar working on Hepatology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D. Tsantoulas has authored 17 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D. Tsantoulas's work include Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (6 papers). D. Tsantoulas is often cited by papers focused on Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (6 papers). D. Tsantoulas collaborates with scholars based in Greece, Norway and United States. D. Tsantoulas's co-authors include Georgia Kostopanagiotou, Vassilios Smyrniotis, John Contis, Kassiani Theodoraki, Angelos Hatzakis, Vana Sypsa, G. Hatzis, Evangelos Akriviadis, N.C. Tassopoulos and I. Ketikoglou and has published in prestigious journals such as Journal of Hepatology, The American Journal of Surgery and Postgraduate Medical Journal.

In The Last Decade

D. Tsantoulas

17 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Tsantoulas Greece 10 394 293 146 44 29 17 501
N. L. Ascher United States 13 427 1.1× 370 1.3× 260 1.8× 56 1.3× 53 1.8× 33 681
Dolors González Spain 5 228 0.6× 212 0.7× 193 1.3× 15 0.3× 30 1.0× 7 453
K Oldhafer Germany 12 324 0.8× 238 0.8× 253 1.7× 78 1.8× 65 2.2× 33 572
Enrique Martínez United States 18 445 1.1× 335 1.1× 267 1.8× 23 0.5× 50 1.7× 35 698
Louis d’Altéroche France 16 644 1.6× 527 1.8× 464 3.2× 74 1.7× 53 1.8× 57 906
Pam Kimball United States 11 188 0.5× 146 0.5× 318 2.2× 35 0.8× 27 0.9× 18 610
Michael I. Abecassis United States 7 304 0.8× 335 1.1× 293 2.0× 13 0.3× 28 1.0× 11 610
Cilénia Baldaia Portugal 10 135 0.3× 316 1.1× 148 1.0× 25 0.6× 22 0.8× 25 455
Cheickna Sylla Senegal 8 383 1.0× 323 1.1× 142 1.0× 70 1.6× 37 1.3× 65 630
J. M. L. Christie United Kingdom 8 588 1.5× 492 1.7× 251 1.7× 21 0.5× 33 1.1× 9 694

Countries citing papers authored by D. Tsantoulas

Since Specialization
Citations

This map shows the geographic impact of D. Tsantoulas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Tsantoulas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Tsantoulas more than expected).

Fields of papers citing papers by D. Tsantoulas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Tsantoulas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Tsantoulas. The network helps show where D. Tsantoulas may publish in the future.

Co-authorship network of co-authors of D. Tsantoulas

This figure shows the co-authorship network connecting the top 25 collaborators of D. Tsantoulas. A scholar is included among the top collaborators of D. Tsantoulas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Tsantoulas. D. Tsantoulas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sypsa, Vana, Giota Touloumi, George Papatheodoridis, et al.. (2005). Future trends of HCV‐related cirrhosis and hepatocellular carcinoma under the currently available treatments. Journal of Viral Hepatitis. 12(5). 543–550. 24 indexed citations
2.
Raptopoulou, M., D. Tsantoulas, I. Ketikoglou, et al.. (2005). The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha‐2b plus ribavirin treatment of naïve and nonresponder chronic hepatitis C patients. Journal of Viral Hepatitis. 12(1). 91–95. 31 indexed citations
3.
Sypsa, Vana, N.C. Tassopoulos, John Boletis, et al.. (2005). Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates. Journal of Viral Hepatitis. 13(1). 19–27. 71 indexed citations
4.
Sypsa, Vana, Giota Touloumi, N. Tassopoulos, et al.. (2004). Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. Journal of Viral Hepatitis. 11(4). 366–374. 37 indexed citations
5.
Smyrniotis, Vassilios, Georgia Kostopanagiotou, Kassiani Theodoraki, D. Tsantoulas, & John Contis. (2004). The role of central venous pressure and type of vascular control in blood loss during major liver resections. The American Journal of Surgery. 187(3). 398–402. 135 indexed citations
6.
Bogdanos, Dimitrios P., Marco Lenzi, M Okamoto, et al.. (2004). Multiple Viral/Self Immunological Cross-Reactivity in Liver Kidney Microsomal Antibody Positive Hepatitis C Virus-Infected Patients is Associated with the Possession of HLA B51. International Journal of Immunopathology and Pharmacology. 17(1). 83–92. 67 indexed citations
7.
Sypsa, Vana, Giota Touloumi, George Papatheodoridis, et al.. (2004). 270 Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. Journal of Hepatology. 40. 84–84. 1 indexed citations
9.
Tassopoulos, N.C., I. Ketikoglou, D. Tsantoulas, et al.. (2003). A randomized trial to assess the efficacy of interferon‐alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C. Journal of Viral Hepatitis. 10(5). 383–389. 5 indexed citations
10.
Vafiadis, Irene, D. Tsantoulas, G. Hatzis, et al.. (2002). IFN- α 2b Monotherapy in Patients with Chronic Hepatitis C and Persistently Normal or Near Normal Aminotransferase Activity: A Randomized, Controlled Study. Journal of Interferon & Cytokine Research. 22(3). 365–369. 9 indexed citations
11.
Smyrniotis, Vassilios, Nikolaos Arkadopoulos, Dimitrios Kehagias, et al.. (2002). Liver resection with repair of major hepatic veins. The American Journal of Surgery. 183(1). 58–61. 18 indexed citations
12.
Paraskevis, Dimitrios, N.C. Tassopoulos, M. Raptopoulou, et al.. (2002). Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. Journal of Virological Methods. 103(2). 201–212. 68 indexed citations
13.
Paraskevis, Dimitrios, et al.. (2001). Development of a novel real-time PCR assay for the quantitation of HBV DNA. Journal of Hepatology. 34. 129–129. 1 indexed citations
14.
Tsantoulas, D., et al.. (1997). The contribution of telemedicine to cardiology. Journal of Telemedicine and Telecare. 3(1_suppl). 63–64. 15 indexed citations
15.
Tsantoulas, D., et al.. (1996). Outpatient teleclinics: six months' experience at the Telemedicine Centre, Sismanoglion Hospital of Athens. Journal of Telemedicine and Telecare. 2(1). 106–107. 1 indexed citations
16.
Tsantoulas, D., et al.. (1996). Outpatient Teleclinics: Six Months’ Experience at the Telemedicine Centre, Sismanoglion Hospital of Athens. Journal of Telemedicine and Telecare. 2(1_suppl). 106–107. 1 indexed citations
17.
Tsantoulas, D., et al.. (1978). The Budd-Chiari syndrome in pregnancy. Postgraduate Medical Journal. 54(636). 686–691. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026